Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders

To explore the whole-brain anatomical and functional abnormalities in drug-naive patients with schizophrenia ,drug-naive patients with BD, drug-naive patients with MDD and healthy controls by using a combination of cross-sectional and longitudinal study designs, including a longitudinal study with 8 weeks of drugs treatment. And explore whether there are shared …

  • 0 views
  • 25 Jan, 2021
  • 1 location
Sequenced Treatment Effectiveness for Posttraumatic Stress

Individuals with PTSD are more likely to engage in unhealthy behaviors such as tobacco use, drug use, alcohol misuse, and have high rates of morbidity/mortality. PTSD negatively impacts marriages, educational attainment, and occupational functioning. Some patients with PTSD can be successfully referred to specialty mental health clinics, but most patients …

selective serotonin reuptake inhibitors
paroxetine
venlafaxine
antidepressants
exposure therapy
  • 24 views
  • 05 Jul, 2021
  • 12 locations
The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients

Among three MAPK families, paroxetine was found to be able to decrease the phosphorylation of ERK. It was reported that paroxetine attenuates the symptoms of collage induced arthritis rats due

DMARD
  • 0 views
  • 10 Mar, 2022
  • 1 location
A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD

pharmacotherapy with paroxetine or venlafaxine - as well as the combination of these two treatments. A randomized trial will be conducted with a large, diverse sample of veterans with PTSD (N = 450) recruited

anxiety
paroxetine
venlafaxine
depression
exposure therapy
  • 0 views
  • 14 Jul, 2022
  • 2 locations
Stellate Ganglion Blockade in Post-Menopausal Women (R01)

Women's Health Initiative (WHI) raised safety concerns about HT. In 2013, the Food and Drug Administration (FDA) approved paroxetine, a selective serotonin reuptake inhibitor (SSRI; 7.5 mg), as the first

hysterectomy
sleep disturbances
bupivacaine
ganglion
paroxetine
  • 158 views
  • 01 Mar, 2022
  • 2 locations
Treatment of Tinnitus With Migraine Medications

Tinnitus represents one of the most common and distressing otologic problems, and it causes various somatic and psychological disorders that interfere with the quality of life. It is well-understood that many factors, such as poor education, lower income, or occupational, and recreational activity associated with high noise exposure, influences the …

depression
anxiety
noise exposure
  • 231 views
  • 15 Jun, 2021
  • 1 location
Evaluation of Drug's Risk in Pregnant Women

Medication during pregnancy can lead to the occurrence of birth defects or neonatal pathologies. Thalidomide or diethylstilbestrol (Distilbene) are prominent examples. Many drugs remain insufficiently evaluated in this area and doctors are too often deprived of relevant information when prescribing drugs in pregnant women.

prenatal
  • 15 views
  • 05 Sep, 2021
  • 1 location
First choIce Antidepressants: General Practitioner's Treatment Approach in the Czech Republic (FIAT)

serotonin reuptake inhibitors (SSRI), e.g. citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, in depression with anxiety and insomnia is preferable trazodone and in severer disorders

  • 0 views
  • 10 Apr, 2022